or Try an Advanced Search...

    Technical Analysis for CDT - Conduit Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    D 3.17 2.26% 0.07
    CDT closed up 2.26 percent on Friday, April 26, 2024, on 18 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical CDT trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Fell Below 50 DMA Bearish 2.26%
    180 Bearish Setup Bearish Swing Setup 2.26%
    Bollinger Band Squeeze Range Contraction 2.26%
    Narrow Range Bar Range Contraction 2.26%
    50 DMA Support Bullish -0.31%
    Older End-of-Day Signals for CDT ...

       Recent Intraday Alerts

    Alert Time
    Bearish 180 Entry about 16 hours ago
    Fell Below Previous Day's Low about 16 hours ago
    Down 1% about 16 hours ago
    Possible NR7 about 16 hours ago
    10 DMA Support 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CDT Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.
    Classification
    Sector: Financial Services
    Industry: Shell Companies
    Keywords: Autoimmune Disease Tax Investigation Stage Specialty Biopharmaceutical

    Is CDT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 19 Conduit Pharmaceuticals Adds Key Leadership Positions
    Mar 19 Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
    Mar 11 Conduit Pharmaceuticals Opens New Laboratory in UK
    Mar 11 Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
    Jan 31 Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    Dec 20 Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
    Nov 29 Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Nov 2 Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
    See more CDT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 25.0
    52 Week Low 0.95
    Average Volume 30,488
    200-Day Moving Average 5.26
    50-Day Moving Average 3.12
    20-Day Moving Average 3.19
    10-Day Moving Average 3.11
    Average True Range 0.25
    RSI (14) 49.75
    ADX 18.37
    +DI 12.56
    -DI 18.30
    Chandelier Exit (Long, 3 ATRs) 3.17
    Chandelier Exit (Short, 3 ATRs) 3.51
    Upper Bollinger Bands 3.45
    Lower Bollinger Band 2.93
    Percent B (%b) 0.46
    BandWidth 16.18
    MACD Line -0.03
    MACD Signal Line -0.02
    MACD Histogram -0.0056
    Fundamentals Value
    Market Cap 234.04 Million
    Num Shares 73.8 Million
    EPS -0.07
    Price-to-Earnings (P/E) Ratio -45.29
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.35
    Resistance 3 (R3) 3.33 3.25 3.32
    Resistance 2 (R2) 3.25 3.20 3.26 3.31
    Resistance 1 (R1) 3.21 3.18 3.23 3.23 3.30
    Pivot Point 3.13 3.13 3.14 3.14 3.13
    Support 1 (S1) 3.09 3.08 3.11 3.11 3.04
    Support 2 (S2) 3.01 3.06 3.02 3.03
    Support 3 (S3) 2.97 3.01 3.02
    Support 4 (S4) 2.99